Overview

Topical ASC-J9 Cream for Acne

Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of topical 0.1% and 0.025% ASC-J9 creams applied twice daily for facial acne compared to vehicle control.
Phase:
Phase 2
Details
Lead Sponsor:
AndroScience Corp
Collaborator:
Orient Europharma Co., Ltd.